Literature DB >> 16185277

Drebrin, an actin-binding, cell-type characteristic protein: induction and localization in epithelial skin tumors and cultured keratinocytes.

Wiebke K Peitsch1, Ilse Hofmann, Jutta Bulkescher, Michaela Hergt, Herbert Spring, Uwe Bleyl, Sergij Goerdt, Werner W Franke.   

Abstract

Isoform E2 of drebrin, an actin-binding protein originally identified in neuronal cells, has recently been identified in diverse non-neuronal cells, mostly in association with cell processes and intercellular junctions. Here, we report on the presence of drebrin in normal human skin, epithelial skin cancers, and cultured keratinocytes. Keratinocytes of normal epidermis contain almost no drebrin but the protein is readily seen in hair follicles. By immunohistochemistry and immunoblot, basal cell carcinomas (BCC) are rich in drebrin, and confocal laser scanning and immunoelectron microscopy show accumulation at adhering junctions, in co-localization with actin and partially with plaque proteins. In squamous cell carcinomas, keratoacanthomas, and in epidermal precancers, drebrin is heterogeneously distributed, appearing as mosaics. Primary keratinocyte cultures contain significant amounts of drebrin enriched at adhering junctions. When epithelium-derived cells devoid of drebrin are transfected with drebrin-enhanced green fluorescent protein, constructs accumulate in the cell periphery, and immunoprecipitation shows complexes with actin. During epidermal growth factor induced formation of cell processes, drebrin retains this junction association, as observed by live cell microscopy. Our results suggest novel functions of drebrin such as an involvement in cell-cell adhesion and tumorigenesis and a potential value in diagnosis of BCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185277     DOI: 10.1111/j.0022-202X.2005.23793.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  Regulation of cellular communication by signaling microdomains in the blood vessel wall.

Authors:  Marie Billaud; Alexander W Lohman; Scott R Johnstone; Lauren A Biwer; Stephanie Mutchler; Brant E Isakson
Journal:  Pharmacol Rev       Date:  2014-03-26       Impact factor: 25.468

Review 2.  Many faces of drebrin: from building dendritic spines and stabilizing gap junctions to shaping neurite-like cell processes.

Authors:  Irina Majoul; Tomoaki Shirao; Yuko Sekino; Rainer Duden
Journal:  Histochem Cell Biol       Date:  2007-02-07       Impact factor: 4.304

3.  Actin-binding protein drebrin regulates HIV-1-triggered actin polymerization and viral infection.

Authors:  Mónica Gordón-Alonso; Vera Rocha-Perugini; Susana Álvarez; Ángeles Ursa; Nuria Izquierdo-Useros; Javier Martinez-Picado; María A Muñoz-Fernández; Francisco Sánchez-Madrid
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

4.  Drebrin regulates neuroblast migration in the postnatal mammalian brain.

Authors:  Martina Sonego; Michelle Oberoi; Jake Stoddart; Sangeetha Gajendra; Rita Hendricusdottir; Fazal Oozeer; Daniel C Worth; Carl Hobbs; Britta J Eickholt; Phillip R Gordon-Weeks; Patrick Doherty; Giovanna Lalli
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

Review 5.  Cofilin-1 and Other ADF/Cofilin Superfamily Members in Human Malignant Cells.

Authors:  Sergey Shishkin; Lidia Eremina; Natalya Pashintseva; Leonid Kovalev; Marina Kovaleva
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

6.  The drebrin/EB3 pathway drives invasive activity in prostate cancer.

Authors:  A E Dart; D C Worth; G Muir; A Chandra; J D Morris; C McKee; C Verrill; R J Bryant; P R Gordon-Weeks
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

7.  Connexin43 Forms Supramolecular Complexes through Non-Overlapping Binding Sites for Drebrin, Tubulin, and ZO-1.

Authors:  Cinzia Ambrosi; Cynthia Ren; Gaelle Spagnol; Gabriel Cavin; Angela Cone; Elena E Grintsevich; Gina E Sosinsky; Paul L Sorgen
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

8.  Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer.

Authors:  Lutfi H Alfarsi; Rokaya El Ansari; Brendah K Masisi; Ruth Parks; Omar J Mohammed; Ian O Ellis; Emad A Rakha; Andrew R Green
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.